Attached files

file filename
EX-99.1 - EXHIBIT 99.1 - CLARIVATE Plcnc10009374x2_ex99-1.htm

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549

FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of report (date of earliest event reported): April 23, 2020

CLARIVATE ANALYTICS PLC
(Exact name of registrant as specified in its charter)


Jersey, Channel Islands
001-38911
N/A
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification No.)

Friars House
160 Blackfriars Road
London SE1 8EZ
United Kingdom
(Address of principal executive offices)
Registrant’s telephone number, including area code: +44 207 433 4000

N/A
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐          Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐          Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐          Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐          Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934:

Title of Each Class
Trading Symbol
Name of Each Exchange on Which Registered
Ordinary shares
CCC
New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (Sec.230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (Sec.240.12b-2 of this chapter).
Emerging growth company          ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.          ☒


Item 7.01.
Regulation FD Disclosure

On April 23, 2020, as a result of the ongoing COVID-19 coronavirus pandemic, Clarivate Analytics Plc (“Clarivate”) issued a press release announcing an update to the logistics of its 2020 Annual General Meeting of Shareholders (“AGM”), scheduled to be held at 2:00 p.m. BST on Thursday, May 7, 2020. A copy of the press release is furnished herewith as Exhibit 99.1 to this Current Report and incorporated by reference herein.

Shareholders may listen to the AGM through our webcast or conference call beginning at 2:00 p.m. BST on Thursday, May 7, 2020 via:

Event address for attendees:
https://clarivatewebinars.webex.com/clarivatewebinars/onstage/g.php?MTID=ed40088458d1750607651d643a993c8fa
Event number:
667 453 471
Event password:
clarivate2020
Audio conference:
To receive a call back, provide your phone number when you join the event, or call the number below and enter the access code.
   
US Toll
   
+1-415-655-0001
   
Show all global call-in numbers
   
Access code: 667 453 471

Any shareholder wishing to submit a question in connection with the AGM may do so at any time by emailing AGM2020@clarivate.com.

The information in this Item 7.01, including Exhibit 99.1 furnished herewith, is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section and shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended, or the Exchange Act, except as otherwise expressly stated in such filing.

Item 9.01.
Financial Statements and Exhibits

(d) Exhibits.

No.
 
Description
 
Press release dated April 23, 2020


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date:          April 23, 2020
CLARIVATE ANALYTICS PLC
     
 
By:
/s/ Richard Hanks
   
Richard Hanks
   
Chief Financial Officer